AssetMark’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$132K Buy
1,528
+973
+175% +$81.4K ﹤0.01% 1574
2026
Q2
$38.5K Buy
555
+362
+188% +$23.9K ﹤0.01% 1938
2026
Q1
$13.3K Buy
193
+148
+329% +$11.6K ﹤0.01% 2216
2025
Q4
$3.97K Buy
45
+19
+73% +$1.62K ﹤0.01% 2545
2025
Q3
$2.16K Buy
26
+13
+100% +$1.13K ﹤0.01% 2612
2025
Q2
$1.22K Buy
13
+8
+160% +$758 ﹤0.01% 2566
2025
Q1
$529 Sell
5
-55
-92% -$5.67K ﹤0.01% 2407
2024
Q4
$5.8K Buy
+60
New +$5.98K ﹤0.01% 1896
2024
Q1
– Sell
-3
Closed -$228 – 2047
2023
Q4
$228 Buy
+3
New +$209 ﹤0.01% 1752
2018
Q1
– Sell
-16
Closed -$1K – 1752
2017
Q4
$1K Buy
+16
New +$671 ﹤0.01% 1650

Other funds holding MMSI

AssetMark's MMSI Position: Q3 2026 in Review

AssetMark increased its Merit Medical Systems (MMSI) stake by 175% in Q3 2026, buying an estimated $81.4K and bringing the position to 1,528 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

AssetMark first reported a position in MMSI in Q4 2017 and has held it in 10 quarters since. 343 funds tracked by Wall St. Rank hold MMSI as of Q3 2026.

  • AssetMark held 1,528 shares of Merit Medical Systems worth $132K as of Q3 2026.
  • AssetMark bought 973 Merit Medical Systems shares in Q3 2026, an estimated $81.4K.
  • Merit Medical Systems made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1574 holding.
  • AssetMark first reported a position in Merit Medical Systems in Q4 2017 and has held it in 10 quarters since.
  • 343 funds tracked by Wall St. Rank held Merit Medical Systems as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.